SOPHSOPHiA GENETICS SA
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Choppy, but holding above its 200-day average. Price is +27% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SOPH is trading
SOPHiA GENETICS SA is +75% over the past year while the S&P 500 is +18%: 57 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +27%
vs 200-day average · a clear uptrend
- RSI (14)
- 33
RSI (14) · neutral
- Below its 52-week high
- 18%
Below its 52-week high
Details›
- Last close2026-10-08
- $7.30
- 1 monthS&P 500 +1.6%
- −4.6%
- 1 yearS&P 500 +18%
- +75%
- 5 yearsS&P 500 +86%
- −58%
- vs 50-day average$7.83
- −6.8%
- 52-week high
- $8.90
- 52-week low
- $3.89
- Annualised volatility
- 73%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $97K
| Year | Return |
|---|---|
| 2026 (year to date) | +56% |
| 2025 | +52% |
| 2024 | −35% |
| 2023 | +129% |
| 2022 | −85% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | +10% |
| Feb | 5 | 3 of 5 | −0.89% |
| Mar | 5 | 2 of 5 | +10% |
| Apr | 5 | 2 of 5 | −3.7% |
| May | 5 | 0 of 5 | −9.3% |
| Jun | 5 | 2 of 5 | −1.6% |
| Jul | 5 | 1 of 5 | −4.8% |
| Aug | 6 | 3 of 6 | +5.3% |
| Sep | 6 | 2 of 6 | +0.90% |
| Oct | 6 | 2 of 6 | −0.03% |
| Nov | 5 | 2 of 5 | +1.2% |
| Dec | 5 | 2 of 5 | −1.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Health Information Services
Ranks #13 of 20 by RyuScore